Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton Jul 08, 2015 4:07pm

81 Views

Post# 23904563

RE:RE:RE:RE:RE:RE:RE:Question for sanfrancisco99

trussell, leftcoast was my target when i decided to start posting here and it wasn't his rubism it was his fraud posting...remember how long he pumped RVX was in the midst of a "creeping takeover" and his pumping is fraud as there is no basis for it ... i have concluded he is trader, like you, but a criminal, unlike you, as he is deeply into the pump-jump-dump of "there is a sucker born every minute"...folks like you i respect as you really don't try to influence stock price

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments